Membrane Type 1-Matrix Metalloproteinase (MMP)-Associated MMP-2 Activation Increases in the Rat Ovary in Response to an Ovulatory Dose of Human Chorionic Gonadotropin

Biology of Reproduction

Volumn 70, Issue 4, 2004, Pages 1024-1032

  Jo, Misung ^a   Thomas, Lauren E ^a   Wheeler, Sarah E ^a   Curry Jr , Thomas E ^a  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

Follicle; Luteinizing hormone; Ovary; Ovulation

Indexed keywords

CHORIONIC GONADOTROPIN; ENZYME PRECURSOR; GELATINASE A; LUTEINIZING HORMONE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; PROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; GRANULOSA CELL; IN SITU HYBRIDIZATION; NONHUMAN; OVARY; OVARY FOLLICLE; OVARY FOLLICLE DEVELOPMENT; OVULATION; PRIORITY JOURNAL; RAT; RIBONUCLEASE PROTECTION ASSAY; THECA CELL; ZYMOGRAPHY;

ANIMALS; CELL MEMBRANE; CHORIONIC GONADOTROPIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; ENZYME PRECURSORS; FEMALE; FOLLICULAR PHASE; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; OVARIAN FOLLICLE; OVARY; OVULATION; PSEUDOPREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TISSUE DISTRIBUTION; TISSUE INHIBITOR OF METALLOPROTEINASE-2;

ANIMALIA; FALLOPIA;

EID: 1642389070     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.103.023499     Document Type: Article

References (42)

1. McCawley LJ, Matrisian LM. Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001; 13:534-540.
2. Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 2000; 1477:267-283.
3. Curry TE Jr, Osteen KG. Cyclic changes in the matrix metalloproteinase system in the ovary and uterus. Biol Reprod 2001; 64:1285-1296.
4. Smith MF, McIntush EW, Ricke WA, Kojima FN, Smith GW. Regulation of ovarian extracellular matrix remodelling by metalloproteinases and their tissue inhibitors: effects on follicular development, ovulation and luteal function. J Reprod Fertil Suppl 1999; 54:367-381.
5. Murdoch WJ. Regulation of collagenolysis and cell death by plasmin within the formative stigma of preovulatory ovine follicles. J Reprod Fertil 1998; 113:331-336.
6. Reich R, Tsafriri A, Mechanic GL. The involvement of collagenolysis in ovulation in the rat. Endocrinology 1985; 116:522-527.
7. Cooke RG III, Nothnick WB, Komar C, Burns P, Curry TE Jr. Collagenase and gelatinase messenger ribonucleic acid expression and activity during follicular development in the rat ovary. Biol Reprod 1999; 61:1309-1316.
8. Curry TE Jr, Mann JS, Huang MH, Keeble SC. Gelatinase and proteoglycanase activity during the periovulatory period in the rat. Biol Reprod 1992; 46:256-264.
9. Curry TE Jr, Komar CM, Burns PD, Nothnick WB. Periovulatory changes in ovarian metalloproteinases and tissue inhibitors of metalloproteinases (TIMPs) following indomethacin treatment. In: Adashi EY (ed.), In Ovulation: Evolving Scientific and Clinical Concepts. New York: Springer Verlag; 2000:265-276.
10. Gottsch ML, Van Kirk EA, Murdoch WJ. Role of matrix metalloproteinase 2 in the ovulatory folliculo-luteal transition of ewes. Reproduction 2002; 124:347-352.
11. Matousek M, Mitsube K, Mikuni M, Brannstrom M. Inhibition of ovulation in the rat by a leukotriene B(4) receptor antagonist. Mol Hum Reprod 2001; 7:35-42.
12. Murphy G, Knauper V, Cowell S, Hembry R, Stanton H, Butler G, Freije J, Pendas AM, Lopez-Otin C. Evaluation of some newer matrix metalloproteinases. Ann N Y Acad Sci 1999; 878:25-39.
13. Butler GS, Butler MJ, Atkinson SJ, Will H, Tamura T, van Westrum SS, Crabbe T, Clements J, d'Ortho MP, Murphy G. The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study. J Biol Chem 1998; 273:871-880.
14. Kinoshita T, Sato H, Okada A, Ohuchi E, Imai K, Okada Y, Seiki M. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J Biol Chem 1998; 273:16098-16103.
15. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995; 270:5331-5338.
16. Liu K, Wahlberg P, Ny T. Coordinated and cell-specific regulation of membrane type matrix metalloproteinase 1 (MT1-MMP) and its substrate matrix metalloproteinase 2 (MMP-2) by physiological signals during follicular development and ovulation. Endocrinology 1998; 139:4735-4738.
17. Liu K, Olofsson JI, Wahlberg P, Ny T. Distinct expression of gelatinase A [matrix metalloproteinase (MMP)-2], collagenase-3 (MMP-13), membrane type MMP 1 (MMP-14), and tissue inhibitor of MMPs type 1 mediated by physiological signals during formation and regression of the rat corpus luteum. Endocrinology 1999; 140:5330-5338.
18. Curry TE Jr, Song L, Wheeler SE. Cellular localization of gelatinases and tissue inhibitors of metalloproteinases during follicular growth, ovulation, and early luteal formation in the rat. Biol Reprod 2001; 65:855-865.
19. Ying SY, Meyer RK. Ovulation induced by PMS and HCG in hypophysectomized immature rats. Proc Soc Exp Biol Med 1972; 139:1231-1233.
20. Jo M, Komar CM, Fortune JE. Gonadotropin surge induces two separate increases in messenger RNA for progesterone receptor in bovine preovulatory follicles. Biol Reprod 2002; 67:1981-1988.
21. Luborsky JL, Dorflinger LJ, Wright K, Behrman HR. Prostaglandin F2 alpha inhibits luteinizing hormone (LH)-induced increase in LH receptor binding to isolated rat luteal cells. Endocrinology 1984; 115:2210-2216.
22. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 1976; 72:248-254.
23. Apte SS, Fukai N, Beier DR, Olsen BR. The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis. J Biol Chem 1997; 272:25511-25517.
24. Pei D, Weiss SJ. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 1996; 271:9135-9140.
25. d'Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 1997; 250:751-757.
26. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990; 6:121-125.
27. Rooprai HK, McCormick D. Proteases and their inhibitors in human brain tumours: a review. Anticancer Res 1997; 17:4151-4162.
28. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994; 370:61-65.
29. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Cao Y, Tryggvason K. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci U S A 2000; 97:4052-4057.
30. Hãgglund AC, Ny A, Leonardsson G, Ny T. Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation. Endocrinology 1999; 140:4351-4358.
31. Russell DL, Salamonsen LA, Findlay JK. Immunization against the N-terminal peptide of the inhibin alpha 43-subunit (alpha N) disrupts tissue remodeling and the increase in matrix metalloproteinase-2 during ovulation. Endocrinology 1995; 136:3657-3664.
32. Driancourt MA, Quesnel H, Meduri G, Prunier A, Hermier D. Luteinization and proteolysis in ovarian follicles of Meishan and Large White gilts during the preovulatory period. J Reprod Fertil 1998; 114:287-297.
33. Wang Z, Juttermann R, Soloway PD. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 2000; 275:26411-26415.
34. Toth M, Bernardo MM, Gervasi DC, Soloway PD, Wang Z, Bigg HF, Overall CM, DeClerck YA, Tschesche H, Cher ML, Brown S, Mobashery S, Fridman R. Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2. J Biol Chem 2000; 275:41415-41423.
35. Caterina JJ, Yamada S, Caterina NC, Longenecker G, Holmback K, Shi J, Yermovsky AE, Engler JA, Birkedal-Hansen H. Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2(Timp-2) gene alters proMMP-2 activation. J Biol Chem 2000; 275:26416-26422.
36. Robker RL, Russell DL, Espey LL, Lydon JP, O'Malley BW, Richards JS. Progesterone-regulated genes in the ovulation process: ADAMTS-1 and cathepsin L proteases. Proc Natl Acad Sci U S A 2000; 97:4689-4694.
37. Yu Q, Stamenkovic I. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev 1999; 13:35-48.
38. Kimura N, Konno Y, Miyoshi K, Matsumoto H, Sato E. Expression of hyaluronan synthases and CD44 messenger RNAs in porcine cumulus-oocyte complexes during in vitro maturation. Biol Reprod 2002; 66:707-717.
39. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 1999; 99:81-92.
40. Nguyen M, Arkell J, Jackson CJ. Human endothelial gelatinases and angiogenesis. Int J Biochem Cell Biol 2001; 33:960-970.
41. John A, Tuszynski G. The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis. Pathol Oncol Res 2001; 7:14-23.
42. Hernandez-Barrantes S, Bernardo M, Toth M, Fridman R. Regulation of membrane type-matrix metalloproteinases. Semin Cancer Biol 2002; 12:131-138.